Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in
Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA
® Portable Capnograph “useful for assessment of the respiratory condition in children with tracheostomy.”
1 EMMA
® provides seamless mainstream capnography for patients of all ages in a compact, easily portable device. The device requires no routine calibration and minimal warm-up time, with accurate end-tidal carbon dioxide (EtCO
2) and respiration rate measurements and continuous EtCO
2 waveforms displayed within 15 seconds.
Masimo EMMA® Capnograph (Photo: Business Wire)
Noting the potential value of a compact and portable way to monitor changes in respiratory status for patients in scenarios where typical inpatient hospital monitoring equipment is less likely to be available, Dr. Masashi Hotta and colleagues sought to evaluate the u
Press release content from Business Wire. The AP news staff was not involved in its creation.
Masimo Monitoring Solutions Promote Newborn and Maternal Safety
March 8, 2021 GMT
Masimo Newborn Sensor (Photo: Masimo)
NEUCHATEL, Switzerland (BUSINESS WIRE) Mar 8, 2021
Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET ® pulse oximetry’s ability to measure during motion and low perfusion has helped newborns, neonates, and pediatric patients like no other pulse oximetry. Not only has Masimo SET ® helped clinicians reduce retinopathy of prematurity (ROP) 1 and improve screening for critical congenital heart disease (CCHD), 2-10 but it has helped push the standard of care for babies to new heights the evidence from CCHD studies with SET ®, for example, has been used in the establishment of screening guidelines used around the world. 11
Masimo Monitoring Solutions Promote Newborn and Maternal Safety yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Masimo Announces CE Marking of the Rad-G™ with Temperature
Tuesday, March 2, 2021 1:26PM IST (7:56AM GMT)
Neuchatel, Switzerland:
Masimo (NASDAQ: MASI) today announced the CE marking of the Rad-G™ with Temperature, a rugged handheld device that provides clinically proven SET
® pulse oximetry, respiration rate from the pleth (RRp
®), and other important parameters alongside clinical-grade, non-contact infrared thermometry. With its long-lasting rechargeable battery, robust rubber casing, light weight, and integrated noninvasive, real-time forehead temperature measurement, Rad-G with Temperature makes it easier for clinicians to quickly assess patients and make informed care decisions anywhere pulse oximetry or vital signs checking is needed in a compact, portable form factor. Coupled with the universal Mini-Clip™ pulse oximeter sensor to provide the ultimate in handheld versatility, Rad-G with Temperatur
Masimo Expands Suite of Advanced Measurements Through Acquisition of UK-Based LiDCO Group Plc
Masimo Expands Suite of Advanced Measurements Through Acquisition of UK-Based LiDCO Group Plc
Masimo (NASDAQ: MASI) today announced that it has successfully completed the acquisition of the LiDCO Group Plc, a leading provider of advanced hemodynamic monitoring solutions (LiDCO). The Company completed the acquisition of 100% of LiDCO on February 2, 2021. LiDCO was founded in 1991, launched its first product in 1999, and began trading on the AIM submarket of the London Stock Exchange in 2001. On January 11, 2021, LiDCO was de-listed from AIM and will be re-registered by Masimo as a UK-based private subsidiary.